Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Advion Launches Chip-Mate™
Monday, June 18, 2012
Company launches an affordable and easy-to-use chip-based nano-LC Ion Source, at ASMS 2012.

Dolomite Launches New Microfluidic Interface
Thursday, June 14, 2012
Flexible and fast solution for PDMS chip connections.

New First of its Kind Constant Pressure Fluid Delivery Syringe Pump
Wednesday, June 06, 2012
New PHD ULTRA™ CP syringe pump to infuse fluids under constant pressure.

ZyGEM and Lockheed Martin Announce Early Release for Rapid DNA Platform
Thursday, May 31, 2012
Companies unveil key component at leading forensics science meeting.

Bio-Rad Introduces First ProteOn™ Sensor Chip
Thursday, May 24, 2012
Product capable of label-free interaction analysis of membrane proteins with peptides and small molecules.

MPI Research Invests in an Additional Gyrolab™ xP Workstation
Wednesday, May 23, 2012
Gyros’ nanoliter-scale immunoassay platform proves commercial success for US-based CRO.

Dolomite Develops Novel Droplet System
Monday, May 21, 2012
New system for the encapsulation of single cells or beads into droplets.

Rubicon Launches Simplest, Fastest, Most Sensitive Sample Prep for NGS
Thursday, May 17, 2012
First product ThruPLEX-FD for fragmented DNA delivers highly sensitive and consistent results from range of sample types in just 2 hours.

IBN's Droplet Array Sheds Light on Drug-Resistant Cancer Stem Cells
Wednesday, May 09, 2012
Cheaper, faster and convenient drug screening using limited samples.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1049
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed